|
N-[(2S,3S,6S)-6-[2-(ethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclopropanecarboxamide
|
123570 |
|
|
N-[(2S,3S,6S)-6-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]propanamide
|
123552 |
|
|
N-[(3-acetylanilino)-sulfanylidenemethyl]-3-chlorobenzamide
|
112353 |
|
|
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]-1-methyl-4-imidazolesulfonamide
|
123536 |
|
|
[seco-4/5][D-Asp3]MC-HtyR
|
221235 |
|
|
N-[(2R,3R,6R)-6-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]propanamide
|
123589 |
|
|
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]propanamide
|
123538 |
|
|
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
|
123517 |
|
|
N-ethyl-2-[(2S,3S,6R)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
|
123510 |
|
|
N-ethyl-2-[(2S,3S,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
|
123586 |
|
|
PE-NMe2(22:5(4Z,7Z,10Z,13Z,16Z)/16:0)
|
171235 |
|
|
alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
|
61235 |
|
|
Thelephantin K
|
212350 |
|
|
digalactosyldiacylglycerol 36:2
|
141235 |
|
|
(10-hydroxy-3-methyl-8,12-dimethylidene-6,13-dioxo-4,14-dioxatricyclo[9.3.0.03,5]tetradecan-9-yl) (Z)-2-methylbut-2-enoate
|
181235 |
|
